Skip to main content

Table 4 CD4+ monthly mortality rate

From: Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients

 > 500 (%)350–500 (%)200–350 (%)100–200 (%)50–100 (%)0–50 (%)
Normal mortality0.0002
Adjusted natural mortality− 0.0005
HIV mortality (raw)0.70001.20001.80008.00008.00008.0000
HIV mortality (monthly adjustment)0.05850.10060.15130.69240.69240.6924
Average HIV mortality0.1850
AOI mortality rate (monthly)
 m0.0411.0204.4760.9603.1003.700
 Fungal0.1060.3310.3480.1350.5911.123
 Protozoal0.0030.0090.5040.0670.1400.270
 Viral0.0060.0130.6960.2140.5231.857
 Other OI0.0470.0870.2240.7162.4603.940
AOI final mortality (monthly)0.0090.0650.3640.1050.3260.530
Average AOI rate0.181
Used in the model0.0670.1650.5150.7961.0181.222
Monthly CD4+ mortality rate0.0670.1650.5150.7961.0181.222
  1. Regarding the correction for all-cause mortality, a standardised mortality ratio by CD4+ cell count was applied as derived by Lewden et al. [35]